StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Impact BioMedical's price to book ratio was 2.4× on Oct 19, 2026, against 0.1× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20262.4×+2.3
2025Jul 31, 20250.2×+0.1
2024Dec 31, 20240.0×–

More Impact BioMedical figures

See a number that looks wrong?